Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with
regard to clinical presentation, proliferative markers, clinical course, and response to …

Objective To describe clinical and pathological characteristics and treatment outcomes in a
large cohort of aggressive pituitary tumours (APT)/pituitary carcinomas (PC). Design …

Aggressive pituitary tumors (APT) refer to pituitary adenomas exhibiting radiological
invasiveness and an unusually rapid tumor growth rate, or clinically relevant tumor growth …

Pituitary adenohypophyseal tumors are considered as benign and termed “adenomas”.
However, many tumors are invasive and a proportion of these exhibit an “aggressive …

Pituitary tumors are benign but not uncommonly invade locally into adjacent tissues such as
the cavernous sinus and dura. Some of these invasive tumors exhibit varying degrees of …

Objective To collect outcome data in a large cohort of patients with aggressive pituitary
tumours (APT)/carcinomas (PC) and specifically report effects of temozolomide (TMZ) …

Aggressive pituitary tumors account for up to 10% of pituitary tumors and are characterized
by resistance to medical treatment and multiple recurrences despite standard therapies …

Abstract The European Society of Endocrinology (ESE) survey reported on the largest cohort
of 125 aggressive pituitary tumours (APT) and 40 pituitary carcinomas (PC). Whilst the …

Objective To investigate bevacizumab as alternative treatment of aggressive pituitary
adenomas after exhaustion of standard therapies. Design and Methods Retrospectively, 3 …

Although usually benign, anterior pituitary tumours occasionally exhibit aggressive
behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional …